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Purpose:  To  identify  and  determine  the  function  of  the  proteins  associated  with  failed  filtering  blebs  following
trabeculectomy.
Methods: Tenon's tissues, obtained during surgery for failed filtering blebs or obtained during cataract surgery on normal
eyes, were analyzed by proteomics. The proteins showing significant differences between the two tissues were selected
for identification by mass spectrometry. The location and expression pattern of ribosomal S6 kinase 2 (RSK2), one of the
altered proteins, were determined. The effect of basic fibroblast growth factor (bFGF) on the expression pattern and
function of RSK2 in NIH3T3 fibroblast cells was then investigated by an RNA knockdown technique.
Results: Eight proteins were found differentially expressed in failed filtering blebs; the identified proteins included those
associated with intracellular signaling pathways. The expression of RSK2, one of the identified proteins, was found to be
decreased compared with that of the control. RSK2 was located in Tenon’s tissue using an immunohistochemical
technique. In culture, the bFGF-induced cell proliferation was inhibited by the RNA knockdown of RSK2. The level of
mRNA and protein expression of actin was increased by RSK2 RNA knockdown, but bFGF-induced protein expression
of actin was not promoted by RSK2 RNA knockdown. Whereas RSK2 RNA knockdown increased the expression and
activity of mitogen-activated protein kinase (MAPK), activation of MAPK induced by bFGF was not promoted by
RSK2 knockdown.
Conclusions: The expression of eight proteins in the failed filtering blebs was significantly different from that in the
Tenon’s capsules used as a control. The effect of RSK2 expression on fibroblast cells suggests that RSK2 may be associated
with wound healing in filtering blebs.
Untreated ocular hypertension can lead to visual field
defects  [1],  and  one  method  of  treating  the  condition  is
trabecular filtration surgery [2]. The objective of filtrating
surgery is to create a functioning filtering bleb that can reduce
the intraocular pressure (IOP). To achieve this, it is essential
that the filtering bleb remains functional. However, the wound
healing process after filtration surgery can be a significant
negative factor in maintaining a functional bleb [3]. Filtrating
surgery, which involves breaking tissue barriers and upsetting
tissue  homeostasis,  is  naturally  incompatible  with  wound
healing,  which  is  the  normal  biological  reaction  to  tissue
damage.  In  fact,  patients  are  often  unable  to  obtain  a
permanent  filtering  effect  after  surgery  due  to  successful
wound healing [4].
Antimetabolic drugs, such as mitomycin-C, are used to
inhibit wound healing during the early postoperative period
[5], and they are therefore frequently adopted as concomitant
therapy for filtrating surgery [6]. However, because cell death
is not actively induced, despite the inhibition of fibroblast
proliferation there may be cases in which a permanent effect
is  not  attained  [7].  Furthermore,  the  targeted  cells  are
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nonspecific,  thus  leading  to  some  related  side  effects  of
toxicity  to  corneal  and  scleral  cells  [8,9].  Therefore,  the
method  by  which  wound  healing  in  the  filtering  bleb  is
controlled  is  a  significant  factor  in  ensuring  good
postoperative results.
Fibroblasts play a significant role in the process of wound
healing [10]. In the first stage of healing, the damaged site is
covered by fibroblasts. The fibroblasts repeatedly divide and
proliferate in order to reach the required number of cells. The
components for protecting the damaged site are then secreted
in  large  amounts.  These  secreted  materials  include
components  of  extracellular  matrix,  such  as  collagen  and
fibronectin  [11].  The  wound  healing  process  coats  the
sclerotomy site, where a scleral flap has been created, with the
proliferated fibroblasts [12].
In the second stage of healing, the proliferated fibroblasts
gradually begin to differentiate; this process is suspected to
be mediated by various factors: transforming growth factor
(TGF)-beta  [13],  connective-tissue  growth  factor  (CTGF)
[14], Rho-associated serine-threonine kinase (ROCK1) [15],
and  the  matrix-metaloproteinases  (MMPs)  [16].  Unlike
undifferentiated  fibroblasts,  the  newly-differentiated
myofibroblasts  transform  the  secreted  extracellular  matrix
into an actin-based component which creates stronger scar
tissue [17]. Although there are several other therapies that
have been attempted as concomitant therapy for secondary
wound healing, none of these therapies has shown sufficient
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2762efficacy. This has hitherto been a major limitation of filtrating
surgery [18-20].
To  find  a  new  way  to  inhibit  wound  healing  (as  an
alternative to the currently available concomitant therapy), it
is necessary to examine the proteins involved in the healing
process  of  filtration  blebs  in  more  detail.  To  do  this  we
collected samples of fibrous Tenon’s tissue of the scleral flap
from  patients  who  required  bleb-revision  surgery  after
filtration surgery and identified the protein families whose
expressions were changed relative to those of control samples.
We found that RSK2, which was one of the identified proteins,
may be involved in the wound healing attributes of a filtering
bleb.
METHODS
Tissue samples and cells: All experiments were performed in
accordance with the Association for Research in Vision and
Ophthalmology’s  statement  on  the  use  of  animals  in
ophthalmic  research.  The  protocol  was  approved  by  the
Institutional Review Board of Hiroshima University.
Samples of Tenon’s capsule tissue covering the scleral
flap  of  failed  filtering  blebs  were  collected  during  bleb
revision surgery from three patients: a 58-year-old male, a 65-
year-old male, and an 87-year-old female. Tenon’s capsule
tissue  samples  were  also  collected  from  three  patients
undergoing cataract surgery, to be used as controls: a 58-year-
old female, an 80-year-old male, and an 89-year-old female.
NIH3T3 cells from mouse embryo fibroblasts were obtained
from  the  American  Type  Culture  Collection  (ATCC;
Manassas,VA).  The  cells  were  maintained  in  Dulbecco’s
modified  Eagle’s  medium  (DMEM;  Sigma-Aldorich,
St.Louis, MO) with 10% fetal bovine serum (FBS), penicillin,
and streptomycin and incubated at 37° C with 5% CO2.
Proteomics:  Sample  preparation,  two-dimensional
electrophoresis, and protein identification were performed as
described in detail elsewhere [21]. In brief, the specimens
were carefully washed in phosphate-buffered saline (PBS)
and solubilized in sample buffer (8 M urea, 4% CHAPS, 0.5%
dithiothreitol  [DTT],  IPG  buffer,  pH  3–10).  The  protein
concentration was measured by the Bradford assay.
Samples,  including  50  µg  protein,  were  treated  by  a
rehydration technique. Isoelectrofocusing, or first-dimension
electrophoresis, was performed on strips with an immobilized
pH  gradient  (pH  3–10  non-linear  gradient,  18  cm;  GE
Healthcare,  Buckinghamshire,  UK)  using  IPGphor  (GE
Healthcare) according to manufacturer’s instructions. After
the isoelectrofocusing, the strips were placed in equilibration
buffer-1 (50 mM Tris-HCl, pH 8.8, 6.0 M urea, 2.0% SDS,
30% glycerol, 1% DTT), and then in equilibration buffer-2
(50  mM  Tris-HCl,  pH  8.8,  6.0  M  urea,  2.0%  SDS,  30%
glycerol, 4% iodoacetamide). The equilibrated strips were
loaded onto SDS-PAGE gel containing 12% polyacrylamide
gel,  and  SDS-polyacrylamide  gel  electrophoresis  (PAGE)
was performed as second-dimension electrophoresis. After
electrophoresis the gels were fixed in 7.5% acetic acid and
20% methanol, and sensitized in 25% ethanol, 0.2% sodium
thiosulfate, and 3.4% sodium acetate. The gels were then
stained with 0.25% silver nitrate and developed with 2.5%
sodium  carbonate  and  0.04%  formaldehyde.  The  silver-
stained gels were scanned on an image scanner (EPSON,
Tokyo, Japan) and the volume of the spots was determined
with  PD-Quest  software  (Bio-Rad  Laboratories,  Hercules,
CA) following the manufacturer’s instructions The software
included  the  equipment  to  correct  and  standardize
automatically the difference of total staining of compared
gels. Three gels from either failed filtering bleb or control
samples were prepared independently and master gels were
generated. The values of the volume of each matched protein
spot on the master gels were compared. Spots with differences
in expression were then identified by mass spectrometry.
The excited protein-containing spots were destained in
30  mM  potassium  ferricyanide  and  100  mM  sodium
thiosulfate,  and  the  gel  samples  were  treated  with  0.1  M
sodium hydrocarbonate and washed with acetonitrile. After
drying, in-gel digestion was performed with trypsin. Then,
0.1% trifluoroacetic acid (TFA) and 10% acetonitrile in water
were used to extract the peptides, and the extract was desalted
on a nano-column. After washing the column with 0.1% TFA
in water, the matrix was eluted with acetnitrile containing
alpha-cyano-4-hydroxycinnamic  acid  directly  onto  the
MALDI target.
Spectra were generated by the MALDI-TOF-MS (Bruker
Daltonics,  Billerica,  MA)  spectrometer.  The  spectra  were
internally  calibrated  using  known  internal  tryptic
autodigestion peptides and searches were made in the NCBI
database  using  ProFound  software.  For  search  criteria,
tolerance was set on 0.5 Da, no restriction on pI, and species
were set as “mammalian.”
Reverse transcription-polymerase chain reaction (RT-PCR):
All of the RNA of the NIH3T3 cells was extracted using
ISOGEN  (Nippongene,  Tokyo,  Japan).  After  the  DNAse
treatment, 1 μg of the RNA samples was used to synthesize
cDNA using the random primer (P6) with a PrimeScript 1st
strand  cDNA  synthesis  kit  (TAKARA,  Tokyo,  Japan)
following the manufacturer’s instructions. Then, PCRs were
performed for α-actin between the sense primer 5'-AGG GAG
TAA TGG TTG GAA TGG G-3' and the antisense primer 5'-
CCA GGG AGG AAG AGG AGG CGG CCG TGG-3', and
for  glyceraldehyde  3-phosphate  dehydrogenase  gene
(GAPDH) between the sense primer 5'-AAT GTG TCC GTC
GTG GAT CT-3' and the antisense primer 5'-TCC ACC ACC
CTG TTG CTG TA-3'. The PCR conditions for actin were
initial denaturation at 95 ºC for 5 min, 35 cycles of 95 ºC for
1 min, 40 ºC for 1 min, and 72 ºC for 1 min; and a final
extension at 72 ºC for 6 min. For GAPDH, the conditions were
initial denaturation at 95 ºC for 5 min, 35 cycles of 95 ºC for
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extension at 72 ºC for 6 min by using LA-Taq polymerase
(TAKARA).  Of  the  resulting  products,  10μl  was
electrophoresed  on  a  1.5%  agarose  gel  containing
ethidiumbromide (0.3 μg/ml) for actin and GAPDH.
Western blot analysis: Western blot analysis was performed
as described in detail [22]. Lysates of the tissues in sample
buffer for proteomics were directly subjected to the SDS-
PAGE technique. The NIH3T3 cells were treated in lysis
buffer (150 mM NaCl, 20 mM Tris-HCl pH 7.4, 1% Triton-
X, 0.5% deoxychorate, 1 mM phenylmethylsulfonyl fluoride,
10  mM  NaF,  20  mg/ml  aprotinin)  and  the  lysates  were
subjected to SDS-PAGE. The proteins were transferred onto
a  nitrocellulose  membrane,  Hybond-C  (GE  Healthcare),
blocked with 5% milk in TBS-T buffer (10 mM Tris-HCl pH
7.4, 150 mM NaCl, 0.1% Tween-20) , and incubated with a
goat polyclonal antibody for RSK2, an anti-actin antibody, an
anti-phospho  MAPK/ERK  antibody  (SantaCruz),  an  anti-
non-phosphorylayted  MAPK/ERK  antibody  (Sigma-
Aldorich), or an anti-αTubullin antibody (SantaCruz). Horse
radish peroxide-conjugated secondary antibodies were used,
and  the  blots  were  developed  with  enhanced
chemiluminescence (ECL).
Immunohistochemistry:  Tissue  samples  were  washed  with
PBS three times and fixed with 4% paraformaldehyde. The
fixed samples were treated with 12%, 15%, and 18% sucrose.
The samples were sectioned on a cryostat, and the sections
were incubated with mouse monoclonal anti-human RSK2
antibody (E-1: Santacruz Biotechnology, Santa Cruz, CA).
The  slides  were  then  incubated  with  fluorescein
isothiocyanate  (FITC)-conjugated  secondary  antibody
(Sigma-Aldorich)  and  mounted  in  Fluoromount  G
(SouthernBiotech,  Birmingham,  AL).  The  sections  were
examined  with  a  confocal  laser  microscope  (BZ-8100:
Keyence Corp., Osaka, Japan).
Cell  biological  assays:  Mouse  RSK2  siRNA  (Santacruz
Biotechnology) was transfected into NIH3T3 cells using the
RNAi  MAX  system  (Invitrogen  Corp.,  Carlsbad,  CA),
according to the manufacturer’s instructions. After culturing
for  24  h  the  cells  were  treated  with  recombinant  basic
fibroblast growth factor (bFGF: Sigma-Aldrich) for 24 h. The
number of living cells was determined by the MTS assay
which was performed with Cell Titer 96 AQUEOUS One
Solution Reagent (Promega, Madison, WI). The products of
the reaction were identified by spectral analysis profiles and
the results were statistically analyzed.
RESULTS
Two-dimensional proteome maps of tissue in failed filtering
blebs: To identify the proteins whose expression was up- or
downregulated in the failed filtering blebs, we compared the
proteome of Tenon tissue from failed filtering blebs to those
from the control Tenon’s capsule. The total tissue lysates were
resolved by two-dimensional gel electrophoresis. We detected
approximately  five  hundred  protein  spots  on  the  two-
dimensional gels after silver staining (Figure 1). We analyzed
three gels for each of the samples to ensure the reliability of
Figure 1. Images of two-dimensional electrophoresis gels with annotation indicating the spots of the identified proteins. The image on the left
shows the silver-stained gel of a failed filtering bleb. The right gel shows the results for a control tissue. Spots S1 through S8 are indicated.
The pI gradient of first dimension electrophoresis is shown above the gels, and the migration of the molecular mass markers for SDS-PAGE
in the second dimension is shown at the side. Gel images shown are representative.
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gel was constructed for each sample using PD-Quest software.
The volume of all of the protein spots was quantified, and
the maximum volume of one spot was 24,806 units. Small and
weak spots whose protein volume was less than 3000 units
were eliminated from analysis. Weak spots are thought likely
to fail protein identification by mass spectrometry in the next
experimental step. This left 96 protein spots from the failed
filtering bleb and 88 from the control. Of these, matched spots
whose  volume  was  expressed  equally  in  both  the  failed
filtering bleb and the control were also eliminated; this left 23
protein spots from the failed filtering bleb and 16 from the
control.  The  remaining  gels  were  carefully  examined  to
confirm whether spots were present or absent. Finally, eight
spots that revealed a significant increase or decrease in volume
were  selected,  and  MALDI  TOF  mass  spectrometry  was
performed  to  identify  their  proteins.  All  eight  spots  were
successfully  identified,  with  high  quality  spectra  and
sufficient reliability.
Four of the eight (50%) proteins, S1, S2, S3, and S4, were
not expressed in the failed filtering bleb and the others, S5,
S6,  S7,  and  S8,  were  specifically  identified  in  the  failed
filtering bleb. We also identified POR in two protein spots, S2
and S3 (Table 1).
Downregulation  of  RSK2  protein  expression  in  the  failed
filtering bleb: Among the identified proteins, we focused on
RSK2  (S1)  whose  expression  was  significantly
downregulated in the failed filtering blebs. (Figure 2A) To
confirm the results of proteomics, western blot analysis was
performed to determine the level of expression of the RSK2
protein. This indicated that expression of RSK2 was lower in
the failed filtering blebs than in the Tenon’s capsule obtained
from the controls (Figure 2B). To confirm expression of RSK2
in the Tenon’s tissue, immunostaining was also performed on
the Tenon’s tissue obtained from the controls. Our results
showed that RSK2 was expressed in the control Tenon’s tissue
(Figure 2C).
Effect of RSK2 RNA knockdown on fibroblasts in vitro: To
further investigate the effects of RSK2, an RNA knockdown
of RSK2 was performed on cultured NIH3T3 cells. The cells
were transfected with the siRNAs of RSK2 and western blot
analysis showed that the endogenous expression of RSK2 was
significantly decreased (Figure 3A). These results confirm
that the process of RNA knockdown of RSK2 acts on the
NIH3T3 cells.
To determine what role RSK2 plays in the proliferation
of fibroblasts, NIH3T3 cells were exposed to bFGF, a known
promoter of fibroblast proliferation [23], in the presence or
absence of RSK2 RNA knockdown. In the absence of bFGF,
the ratio of the living NIH3T3 cells with the RNA knockdown
was 0.842±0.057 (average±standard error of mean) which
was not significantly different from that in non-treated cells
at 0.96±0.018. The addition of bFGF significantly increased
the number of living NIH3T3 cells to 1.468±0.263, and the
simultaneous  presence  of  RSK2  RNA  knockdown
significantly  decreased  the  number  of  living  cells  to
1.053±0.061 (Figure 3B). These results indicate that RSK2
RNA knockdown inhibited the proliferation of fibroblasts
induced by bFGF, and thus we believe that RSK2 may be
associated with wound healing.
Effect of RSK2 on actin expression, as a marker of wound
healing and MAPK activity:  To investigate the molecular
function of RSK2, we observed the expression of actin and
MAPK (mitogen-activated protein kinase) in the absence or
presence of bFGF. RSK2 RNA knockdown promoted both
mRNA and protein expression of actin in the absence of bFGF
(Figure 4A,B). Although treatment with bFGF also induced
the  protein  expression  of  actin,  this  upregulation  of  actin
TABLE 1. DIFFERENTIALLY EXPRESSED PROTEINS IDENTIFIED BY PROTEOMICS FROM TENON TISSUE OBTAINED FROM FAILED FILTERING BLEB.
Sequence Theoretical value Experimental value
Spot Protein Probability Est'd Z Coverage (%) ncbi ID pH (kDa) pH (kDa)
Spots identified only in control tissue
S1 ribosomal protein S6 kinase 3 1.0e+000 1.43 21 AAC82495.1 6.1 66.28 4.5 42
S2 POR2 1.0e+000 1.72 27 AAG33132.1 7.2 61.89 3.5 42
S3 POR2 1.0e+000 1.2 21 AAG33132.1 7.2 61.89 4.0 42
S4 GalNAc alpha-2,6-sianyltransferase 1 1.0e+000 0.85 18 NP_060884 10.1 68.55 5.0 60
Spots identified only in the failed filtering bleb
S5 Fibrin-beta 1.0e+000 1.67 32 0401173A 8.3 51.53 8.0 55
S6 PSAPL1 protein 5.3e+001 0.3 7 AAH68579.1 8.7 60.74 8.5 55
S7 Hypothetical protein 9.8e-001 1.42 32 CAD38695.1 10.1 68.73 6.0 50
S8 1-aminocyclopropane1-carboxylate
synthetase
1.0e+000 2.43 22 NP_115981.1 6.0 57.88 8.5 35
S1 to S8 represent ID number of spots and sequence coverage, and the theoretical value of pI and Mr were obtained from the
Pro Found search. The calculations of the experimental pI and Mr were based on the migration of the protein on a 2D gel.
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Mr Mrexpression  was  not  promoted  by  RSK2  RNA  knockdown
(Figure 4B). Expression of MAPK, however, was promoted
by RSK2 RNA knockdown and MAPK activity was also up-
regulated in the absence of bFGF. The MAPK activity induced
by treatment with bFGF was not promoted by RSK2 RNA
knockdown (Figure 4C). Thus, the expression of actin was
regulated by RSK2 via downregulation of MAPK, and we
know that expression of actin is an important component of
wound healing. This means that RSK2 may have an inhibitory
effect on wound healing by acting on fibroblasts, and this
supports our observation that RSK2 was downregulated in
failed filtering blebs.
DISCUSSION
Although the ideal control for the failed filtering bleb is a
specimen from the eye of a successful trabeculectomy, it is
impossible, clinically and ethically, to collect samples from a
functional filtering bleb. So, our investigation was limited
physiologically,  but  samples  derived  from  the  results  of
proteomics  showed  several  protein  candidates  that  might
contribute to the failure of filtering blebs. One of these, RSK2,
is one of the three mammalian homologs of RSKs [24] and
was downregulated in the failed filtering blebs. RSK2 inhibits
the differentiation of fibroblast cells in the absence of bFGF;
it is involved in the mitogen-activated protein kinase (MAPK)
pathway  and  dissociates  from  MAPK  following  mitogen
stimulation [25]. MAPK activates growth factors involved in
the phosphorylation of the cyclic adenosine monophosphate-
response element-binding protein (CREB), a critical regulator
of early gene transcription [26]. Although an activated MAPK
phosphorylates  RSK2  [27],  RSK2  itself  reduces  the
expression and phosphorylation of MAPK. It is suspected that
Figure  2.  This  shows  changes  in
expression of RSK2; a portion of 2D-gel
that includes the protein spot of RSK2
(arrow) is shown at high magnification.
A: Total lysates of tissue sample from
failed filtering blebs (Failed bleb) and
from  Tenon  obtained  during  cataract
surgery (Control) were applied to 12%
polyacrylamide gel (SDS PAGE), and
blotted  with  anti-RSK2  antibody.
Migration  position  of  RSK2  is
indicated. B: The panel on the left shows
RSK2  expression  in  Tenon’s  capsule
derived  from  cataract  surgery  stained
with an anti-RSK2 antibody. The right-
hand  panel  is  stained  without  the
primary antibody, as a negative control.
Arrows show the actual protein spots,
identified as RSK2.
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activity of MAPK. Furthermore, actin is one of the main
components responsible for wound healing of filtering blebs,
and RSK2 phosphorylates actin-binding protein, ABP-280
[28], inducing the activation of RSK2. These findings suggest
that it is the MAPK signaling, whose activity is reduced by
RSK2, that promotes wound healing, and this is compatible
with our finding that RSK2 expression was decreased in failed
filtering blebs.
RSK2  promotes  the  activation  of  MAPK  induced  by
bFGF and promoted the function of bFGF, cell proliferation,
and differentiation of fibroblast cells. FGF is a ligand of the
receptor for the MAPK signaling pathway and regulates the
cell cycle. bFGF binds directly to RSK2 and activated RSK2
promotes  the  cell  cycle  from  G0  phase  to  G1  phase  [29].
Downregulation  of  RSK2  inhibits  the  proliferation  of
fibroblasts in the filtering bleb and is suspected to be needed
for the preparation of the post-stage of wound healing, the
differentiation of fibroblasts to myofibroblasts. Furthermore,
RSK2 has a multiple function in the process of transcription
and MAD1 (MAX dimerization protein-1), which suppresses
myc-mediated cell transformation, is one of the substrates
[30].  RSK  also  phosphorylates  filamin-A,  a  membrane-
associated, cytoskeletal protein that crosslinks actin filaments
[31]. Thus, RSK is also linked to biological processes in the
process of post-translational modification and could have a
role in the post-stage of wound healing.
ST6GAlNAc1 (GalNAc alpha-2, 6-sianyltransferase 1:
S4) was also identified as one of the downregulated proteins
in failed filtering blebs. ST6GAlNAc1 reduces the number of
O-glycosylation sites on the cell surface glycoconjugate [32],
and its activity is important for shaping the cell phenotype
Figure  3.  This  shows  the  effect  of
RSK2  siRNA  on  proliferation  of
fibroblasts.  A:  NIH3T3  cells  were
transfected  with  RSK2  siRNAs  and
cultured for 24 h. After that, cells were
treated with or without 0.33 μg/ml bFGF
for 24 h. Cells were lysed and the whole
cell  extract  was  loaded  onto  7.0%
polyacrylamide  gel  (SDS-PAGE).
Endogenous  RSK2  expression  was
blotted with an anti-RSK2 antibody as
indicated. Blots with an anti-α tubulin
antibody  were  also  performed  to
standardize  the  total  protein  volume
loaded. B: The number of living cells
was estimated by MTS assays and three
independent  experiments  were
performed. The results were statistically
analyzed and the ratio of surviving cells
(viable) is shown as the mean±standard
error  of  the  means.  (The  asterisk
indicates a p<0.05, Student’s t test).
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S3), which is a metabolic anaerobic enzyme that is reducted
by  metronidazole  [34],  was  also  downregulated  in  failed
filtering  blebs.  The  protein  ACC  synthetase  (1-
aminocyclopropane1-carboxylate synthetase: S8), one of the
transcriptional modulators [35], was upregulated in the failed
filtering bleb. These metabolic enzymes may play important
roles during wound healing, but the exact process has still not
been determined. The protein functions of PSAPL1 (S6) and
hypothetical protein (S7) were not analyzed in this study.
They should be investigated further to determine their role in
failed filtering blebs.
In  conclusion,  proteome  analyses  identified  eight
proteins in failed filtering blebs whose level of expression was
significantly  different  from  that  in  control  tissues.  A
functional analysis of RSK2 indicated that RSK2 may be
associated with wound healing of filtering blebs.
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